12 completed, 2 active not recruiting, 1 not yet recruiting. 8 Not applicable, 2 Phase 1, 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Completed 5, Active not recruiting 2, Not yet recruiting 1 |
| Phase 1 | 2 | Completed 2 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Prevention and Control: new trials by email Literature Review of Prevention and Control trials Research Report on Prevention and Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Digital Defocus Vision Training With Low-Concentration Atropine on the Prevention and Control of Myopia in Children: A Clinical Study For the experimental group,Virtual reality-based digital defocus training combined with 0.02% atropine eye drops, For the control group, one drop of 0.02% atropine eye drops was instilled into each eye at bedtime daily, combined with full-time wear of fully corrected multi-zone positive optical defocus (DIMS) spe - Myopia, Prevention and Control | Not applicable | Not yet recruiting | Beijing Tongren Hospital | 100 | 2026-08-20 | 2026-07-24 |
| Prevention Workshop to Address Bullying Behaviors in Schools Tous Épanouis à l'École (TEAL Program), Standard Health Education Sessions - Bullying of Child, Child Behavior Disorders | Not applicable | Active not recruiting | University Hospital, Grenoble | 900 | 2024-10-01 | 2025-02-19 |
| Cognitive-Behavioral Intervention to Increase Tummy Time Practice and Maintain Healthy Weight in Infants Tummy Time for the prevention of childhood obesity - Obesity/therapy, Prevention and Control | Not applicable | Active not recruiting | Universidad Autonoma de Nuevo Leon | 144 | 2024-09-02 | 2025-02-20 |
| A Combination of an Inhaled Budesonide and Ipratropium in Patients at Risk of Developing ARDS combined standard aerosolized doses of budesonide (0.5 mg/2 mL) every 12 hours and ipratropium bromide (500/2 mL) every eight hours for up to five days, Placebo - ARDS, Prevention and Control | Phase 1 / Phase 2 | Completed | Damanhour University | 119 | 2024-05-01 | 2025-02-06 |
| Helicobacter Pylori Infection and Gastric Diseases in Lao PDR: First Community-Wide Population-Based Study Gastric Cancer Screening, Prevention and Control | Completed | Zero Helicobacter IGAN Network | 1251 | 2023-12-18 | 2026-01-14 | |
| To Assess the Efficacy of a Localized Focal Vibration Tool on the Muscular Response to Five Countermovement Jumps in Healthy Soccer Players Non invasive focal vibration with heads, Non invasive focal vibration without heads - Prevention and Control, Healthy People Programs | Not applicable | Completed | University Rovira i Virgili | 5 | 2022-01-02 | 2025-05-02 |
| Effects of a Neuromuscular Training Ankle Preventive Program in Soccer Player PENMT (Experimental Group), FIFA 11+ (Control Group) - Prevention and Control | Not applicable | Completed | Universidad Autónoma de Manizales, Colombia | 40 | 2021-07-07 | 2023-01-18 |
| Evaluation of the Effectiveness and Safety of Supratube Device Supranav - Intensive Critical Unit, Pneumonia | Not applicable | Completed | Fundación Cardiovascular de Colombia | 108 | 2018-05-29 | 2022-04-20 |
| PrOVE QUERI Project #1 Webinar, Promotion, and Tool Access, LEAP, Audit and Feedback - Prevention and Control | Completed | VA Office of Research and Development | 17033 | 2016-11-15 | 2024-12-31 | |
| Break the Cycle: Prevention for Reducing Initiation Into Injection Drug Use Break the Cycle Intervention, Bacterial Infection Prevention - Substance Abuse, Intravenous, Prevention and Control | Not applicable | Completed | New York University | 402 | 2016-08-31 | 2025-05-25 |
| An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers Direct Oral Anticoagulant (DOAC) - Stroke, Prevention and Control | Completed | Bayer | 247 | 2015-09-01 | 2017-02-16 | |
| An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres Direct Oral Anticoagulant (DOAC) - Stroke, Prevention and Control | Completed | Bayer | 792 | 2015-05-01 | 2017-02-16 | |
| The Value of Our Health El Valor de Nuestra Salud Store Intervention - Prevention of Chronic Disease, Prevention and Control | Not applicable | Completed | San Diego State University | 370 | 2011-10-01 | 2015-11-17 |
| Experimental PfSPZ Vaccine in Adults Without Malaria PfSPZ - Malaria, Prevention and Control | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 64 | 2011-09-14 | 2018-07-05 |
| Effect of High-Legume Diet on Colorectal Cancer Risk LIFE - Inflammation, Prevention and Control | Early Phase 1 | Completed | National Cancer Institute (NCI) | 65 | 2005-08-03 | 2019-12-16 |
Atrial Fibrillation (2) · Stroke (2) · Adenoma (1) · Ankle Injuries (1) · Child Behavior Disorders (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Health Behavior (1) · Health Education (1) · Helicobacter Infections (1) · Inflammation (1) · Insulin Resistance (1) · Joint Instability (1) · Malaria (1) · Myopia (1)
Pathological Conditions, Signs and Symptoms (5) · Pathologic Processes (4) · Behavior (3) · Infections (3) · Arrhythmias, Cardiac (2) · Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Health Behavior (2) · Heart Diseases (2)
N(4)-oleylcytosine arabinoside (2) · Control Groups (1) · Ipratropium (1) · SpeA protein, Streptococcus pyogenes (1)
Bayer (2) · Beijing Tongren Hospital (1) · Damanhour University (1) · Fundación Cardiovascular de Colombia (1) · National Cancer Institute (NCI) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · New York University (1) · San Diego State University (1) · Universidad Autonoma de Nuevo Leon (1) · Universidad Autónoma de Manizales, Colombia (1) · University Hospital, Grenoble (1) · University Rovira i Virgili (1) · VA Office of Research and Development (1) · Zero Helicobacter IGAN Network (1)
United States (5) · Spain (3) · Colombia (2) · China (1) · Egypt (1) · Estonia (1) · France (1) · Laos (1) · Mexico (1)
Alba L Ramirez Sarmiento, PhD (1) · Anneli Uuskula, PhD (1) · Bastien Boussat, MD, PhD (1) · Don Des Jarlais, PhD (1) · Gloria Carvajal Carrascal, PhD (1) · Guadalupe X Ayala, PhD (1) · Jorge A Mayo Abarca, Master (1) · Lina Ma Montealegre, Msc (1) · Matthew R Young, Ph.D. (1) · Robert A Seder, M.D. (1) · Tanner Caverly, MD MPH (1)
PMID 23929949, PMID 24842220, PMID 25642687, PMID 31323197, PMID 35177070, PMID 35363144, PMID 39627771, PMID 40161252, PMID 41819813
5DP1DA039542-05 (1), R01CA140326 (1)